Completed NA INTERVENTIONAL 1-arm NCT05825352

PMCF Study to Evaluate Performance and Safety of Ocular Drops Based Upon Carmellose Used to Relieve Dry Eye Symptoms

An Interventional, Non-comparative, Single-center Post Marketing Clinical Follow-up (PMCF) Study to Evaluate Performance and Safety of Ocular Drops Based Upon Carmellose Used to Relieve Dry Eye Symptoms

Sponsor: C.O.C. Farmaceutici S.r.l.

Conditions Dry Eye Dry Eye Disease Kerato Conjunctivitis Sicca

Interventions Carmellose eye drops

Updated 4 times since 2023 Last updated: May 3, 2023 Started: Mar 24, 2022 Primary completion: Jul 29, 2022 Completion: Jul 29, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Dry Eye and Dry Eye Disease and is currently completed. C.O.C. Farmaceutici S.r.l. leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2023 — Jul 2024 [monthly]

Completed NA
May 2023 — Jun 2023 [monthly]

Completed NA

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

C.O.C. Farmaceutici S.r.l.

Data source: C.O.C. Farmaceutici S.r.l.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catanzaro, Italy